Sort   by:  
 Page size 
UnknownRecurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data.
Not available
S-EPMC9023005 | biostudies-literature
UnknownA 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.
Not available
S-EPMC7967962 | biostudies-literature
UnknownGenetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
Not available
S-EPMC8059115 | biostudies-literature
UnknownSequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Not available
S-EPMC7875770 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
Sort   by:  
 Page size